ArticleScience advances2026
A pontomesencephalic-mesolimbic circuit modulates activity-based anorexia.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anorexia nervosa (AN) is a psychiatric disorder with a high mortality rate. The compulsive nature of the disorder leads to an emerging dopamine (DA)-centered hypothesis. However, the circuit mechanism of AN remains elusive. By examining a pontomesencephalic-mesolimbic circuit, which is implicated in anorexia-like and reinforcement behaviors in naïve mice, we found that this pathway modulates activity-based anorexia (ABA), a well-established animal model of AN. Specifically, glutamatergic lateral parabrachial nucleus (LPBN) neurons indirectly inhibited medial ventral tegmental area (VTA) DA neurons through local GABAergic interneurons. Chronic activation of the LPBN-VTA circuit exacerbated ABA symptoms, whereas circuit suppression alleviated them, demonstrating its sufficiency and necessity. Moreover, VTA DA neurons exhibited impaired high-conductance calcium- and voltage-dependent potassium (BK) channel currents. Pharmacological enhancement of this channel improved the retention rate in ABA mice. Our results elucidate the critical role of the LPBN-VTA circuit and potential channel pathology, which may serve as a key to the development of drug treatments and intervention strategies for AN.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.